AKSTON BIOSCIENCES CORP has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are PROBE INTERNAT, PASTAN IRA H and DAIICHI SANKYO EUROPE GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Zion Todd C | 18 |
#2 | Lancaster Thomas M | 17 |
#3 | Sathiyaseelan Thillainayagam | 8 |
#4 | Murikipudi Sylaja | 7 |
#5 | Todd C Zion | 2 |
#6 | Lancaster Thomas | 2 |
#7 | Thomas M Lancaster | 2 |
#8 | Zion Todd | 2 |
#9 | Lancater Thomas M | 1 |
#10 | Thillainayagam Sathiyaseelan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021011827A1 | Ultra-long acting insulin-fc fusion proteins and methods of use | |
AU2019291945A1 | Ultra-long acting insulin-Fc fusion proteins and methods of use | |
WO2018107117A1 | Insulin-fc fusions and methods of use |